Miller, B. W., Morton, J. P., Pinese, M., Saturno, G., Jamieson, N. B., McGhee, E., . . . Sansom, O. J. (2015). Targeting the LOX/hypoxia axis reverses many of the features that make pancreatic cancer deadly: Inhibition of LOX abrogates metastasis and enhances drug efficacy. EMBO Mol Med.
Chicago-stil citatMiller, Bryan W., et al. "Targeting the LOX/hypoxia Axis Reverses Many of the Features That Make Pancreatic Cancer Deadly: Inhibition of LOX Abrogates Metastasis and Enhances Drug Efficacy." EMBO Mol Med 2015.
MLA-referensMiller, Bryan W., et al. "Targeting the LOX/hypoxia Axis Reverses Many of the Features That Make Pancreatic Cancer Deadly: Inhibition of LOX Abrogates Metastasis and Enhances Drug Efficacy." EMBO Mol Med 2015.
Varning: dessa hänvisningar är inte alltid fullständigt riktiga.